1.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 55 Sponsor: Other Protocol IDs: GMALL02, NCT00198978
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL01, NCT00198991
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: 0 to 75 Sponsor: Other Protocol IDs: LPA 2005, NCT00408278
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: 15 and under Sponsor: Other Protocol IDs: LAL-BR/2001, NCT00526175
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and under Sponsor: Other Protocol IDs: LAL-AR-N-2005, NCT00526409
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and under Sponsor: Other Protocol IDs: 2007016, NCT00846703
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: LAL-AR/2003, NCT00853008
|
|
8.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: RJ-2010-56, NCT01358253
|
|
9.
|
Phase: Phase IV Type: Treatment Status: Active Age: 55 and under Sponsor: Other Protocol IDs: LAL Ph-2008, NCT01491763
|
|
10.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 1 to 17 Sponsor: Other Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 25 to 65 Sponsor: Other Protocol IDs: JALSG ALL202-O, NCT00131027
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to under 30 Sponsor: NCI Protocol IDs: COG-AALL0433, AALL0433, NCT00381680
|
|
13.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: CDR0000528029, ALL-BFM-2000, EU-20682, NCT00430118
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: APL0406, GIMEMA-SAL-APL0406, EUDRACT-2006-006188-22, GIMEMA-DSL-APL0406, EU-20725, NCT00482833
|
|
15.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and under at diagnosis Sponsor: NCI Protocol IDs: COG-AALL0631, AALL0631, NCT00557193
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and under Sponsor: NCI, Other Protocol IDs: TOTXVI, 5R01CA140729, 5F32CA141762, NCT00549848
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and under Sponsor: Other Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to 17 Sponsor: Other Protocol IDs: NOPHO ALL2008 consolidation, NCT00816049
|
|
19.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057
|
|
20.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 25 to 65 Sponsor: Other Protocol IDs: UCL-08-0167, UCL/08/0167, EU-21009, EUDRACT-2009-012717-22, UCL-UKALL14, MREC-09-H0711-90, NCRI-UCL-08-0167, CRUK-C27995-A9609, NCT01085617
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 18 Sponsor: Other Protocol IDs: AIEOP-BFM ALL 2009, NCT01117441
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to < 10 Sponsor: NCI Protocol IDs: COG-AALL0932, AALL0932, NCT01190930
|
|
23.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 30 Sponsor: NCI Protocol IDs: COG-AALL1131, AALL1131, NCT01406756
|
|
24.
|
Phase: Phase III Type: Educational/Counseling/Training, Treatment Status: Active Age: 12 to 25 Sponsor: NCI Protocol IDs: COG-ACCL1033, ACCL1033, NCT01503632
|
|
25.
|
Phase: Phase III Type: Behavioral study, Treatment Status: Active Age: 1 to under 31 Sponsor: NCI, Other Protocol IDs: CDR0000514500, COG-AALL0434, AALL0434, NCT00408005
|